Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Global Anemia Gene Detection Kits Market Growth 2023-2029
... to grow at a CAGR of 4.8% from 2023 to 2029. United States market for Anemia Gene Detection Kits is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Hemophilia Treatment Drugs Market Research Report 2023(Status and Outlook)
... Treatment Drugs Market Size was estimated at USD 10830.00 million in 2022 and is projected to reach USD 13778.78 million by 2029, exhibiting a CAGR of 3.50% during the forecast period. Bosson Research’s latest report ... Read More
-
Iron Deficiency Anemia (IDA) Therapy Market Forecasts to 2028 – Global Analysis By Therapy (Parenteral Iron Therapy, Oral Iron Therapy, Red Blood Cell Transfusion Therapy and Other Therapies), Therapy Area (Congestive Heart Failure (CHF), Renal, Obstetrics & Gynaecology, Oncology, Inflammatory Bowel Disease and Other Therapy Areas), Age, End User and By Geography
... Obstetrics & Gynaecology, Oncology, Inflammatory Bowel Disease and Other Therapy Areas), Age, End User and By Geography According to Stratistics MRC, the Global Iron Deficiency Anemia (IDA) Therapy Market is accounted for $1.87 billion in ... Read More
-
Global Thalassemia Market Size study & Forecast, by Therapeutic Class (Iron Chelating Drugs), by Pipeline (Gene Therapy) and Regional Analysis, 2022-2029
... to grow with a healthy growth rate of more than 5% over the forecast period 2022-2029. According to Centers for Disease Control and Prevention - Thalassemia can be defined as an inherited blood disorder caused ... Read More
-
Bleeding Disorders Market By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Treatment Type (Factor Replacement Therapy, Drug Therapy), By Distribution Channel (Hospital Pharmacies, Drug stores and retail pharmacies, Online pharmacies): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Opportunity Analysis and Industry Forecast, 2023-2032 The bleeding disorders market was valued at $13,789.66 million in 2022 and is estimated to reach $25,974.82 million by 2032, exhibiting a CAGR of 6.6% from 2023 to 2032. ... Read More
-
Middle East and Turkey Hemophilia Treatment Market, By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Desmopressin), By Disease Indication (Hemophilia A, Hemophilia B, and Hemophilia C), and By Country (Turkey, Egypt, Israel, Saudi Arabia, UAE, and Rest of Middle East)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Egypt, Israel, Saudi Arabia, UAE, and Rest of Middle East)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Hemophilia is rare disorder, in which the blood does not clot properly, and Bleeding after an ... Read More
-
Hemoglobinopathies- Market Insights, Competitive Landscape, and Market Forecast - 2027
... is expected to advance at a respectable CAGR forecast till 2027 owing to the increasing prevalence of various hemoglobin disorders and the increasing research & developmental activities concerning to the hemoglobinopathies across the globe The ... Read More
-
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Hemophilia A (Factor VIII Deficiency) Clinical trials scenario. This report provides ... Read More
-
Global Anemia in Pregnancy Market Growth 2023-2029
... CAGR of % from 2023 to 2029. United States market for Anemia in Pregnancy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
... and End User (Hospitals, Clinics, and Others) The blood plasma derivatives market is expected to reach US$ 51,119.24 million by 2028 from US$ 29.886.12 million in 2022; it is estimated to record a CAGR of ... Read More
-
Global Haemophilia Drug Market Growth (Status and Outlook) 2023-2029
... comprehensive analysis by region and market sector of projected Haemophilia Drug sales for 2023 through 2029. With Haemophilia Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in ... Read More
-
Global Anemia Treatment Market Growth (Status and Outlook) 2023-2029
... carry oxygen.[5] When anemia comes on slowly, the symptoms are often vague and may include feeling tired, weakness, shortness of breath or a poor ability to exercise. LPI (LP Information)' newest research report, the “Anemia ... Read More
-
Global Sickle-cell Anemia Therapeutics Market Growth (Status and Outlook) 2023-2029
... the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS). LPI (LP Information)' newest research report, the ... Read More
-
Global Renal Anemia Therapeutics Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Renal Anemia Therapeutics sales for 2023 through 2029. With Renal Anemia Therapeutics sales broken down by region, market sector and sub-sector, this report ... Read More
-
Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 1.6 million diagnosed prevalent cases of ITP in 2023 across 16 pharmaceutical markets. There are four leading marketed innovator drugs for the treatment of ITP, majority of marketed products are thrombopoietin receptor agonist. R&D activity ... Read More
-
Thalassemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Thalassemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Thalassemia. Report includes ... Read More
-
Global Bleeding Disorders Treatment Market Size study & Forecast, by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), by Drug Class (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others) and Regional Analysis, 2022-2029
... and Regional Analysis, 2022-2029 Global Bleeding Disorders Treatment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast ... Read More
-
Aplastic Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Aplastic Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Chemotherapy Induced Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Chemotherapy Induced Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule ... Read More
-
Iron Deficiency Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Iron Deficiency Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule ... Read More
-
Anemia in Chronic Kidney Disease (Renal Anemia) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Anemia in Chronic Kidney Disease (Renal Anemia) pipeline candidate, details of ... Read More
-
Fanconi Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Fanconi Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Global Hemophilia Drugs Market Growth 2023-2029
... factors and more promising drugs are on their way to get launched in this market. For instance, follow up data from phase I/II study of hemophilia medicine ‘Emicizumab’ by Roche has demonstrated promising results regarding ... Read More
-
Global Anemia and Vitamin Test Market Growth (Status and Outlook) 2023-2029
... important to functioning of the human being. Haemoglobin is a part of RBC that carries oxygen to the various body tissue. If a person has less number of RBC or low level of haemoglobin that ... Read More
-
Iron Deficiency Anemia Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... to register solid growth in the sector in 2023 and beyond. The Iron Deficiency Anemia market report analyzes the Iron Deficiency Anemia market growth opportunities, trends, insights, and market size outlook across types, applications, and ... Read More
Research Assistance
